The company has finalised its €1.08bn share repurchase programme earlier than expected, buying back nearly 13 million shares and plans to cancel over 12m shares in early 2026
Corpowell’s VeCollal has raised new funding from Seventure Partners to accelerate global expansion of its biomimetic, plant-based collagen technology — unveiling clinical...
Get breaking news, product releases, technical papers, innovation features, trend reports and live content agendas covering the entire industry.